FivePharma

FivePharma

Dublin, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

FivePharma is a Dublin-based, privately-held service provider to the global life sciences industry, specializing in quality, compliance, and regulatory consulting. With a network of approximately 41 associates and operations in 40 countries, the company has served over 150 clients and conducted more than 900 audits since its founding. Its business model is entirely service-based, generating revenue through flexible contracts for auditing, interim management, training, and regulatory strategy, particularly helping clients navigate complex EU and international market access requirements.

Drug DeliverySmall Molecules

Technology Platform

Integrated service model built on a global network of Qualified Persons (QPs), Responsible Persons (RPs), and regulatory experts providing auditing, training, consulting, and interim management for GMP, GCP, GDP, and market access compliance.

Opportunities

Growth is driven by increasing regulatory complexity globally, the rise of virtual biotech companies outsourcing all quality functions, and the ongoing need for expert navigation of EU and international market access post-Brexit.
Expansion into high-growth regions like Asia presents further opportunity.

Risk Factors

Key risks include heavy reliance on a network of key expert associates, making the firm vulnerable to talent attrition.
The business is also exposed to cyclical downturns in biotech funding and faces intense competition from both large consultancies and individual practitioners.

Competitive Landscape

FivePharma competes in a fragmented market that includes large multinational Contract Research Organizations (CROs) and consulting firms, niche regulatory consultancies, and independent Qualified Persons. Its differentiation lies in its tailored approach, global associate network, and deep specialization in EU regulatory affairs and QP services.